Rosewich M - Search Results

1

Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.

Kirschner M, Maurer A, Wlodarski MW, Ventura Ferreira MS, Bouillon AS, Halfmeyer I, Blau W, Kreuter M, Rosewich M, Corbacioglu S, Beck J, Schwarz M, Bittenbring J, Radsak MP, Wilk CM, Koschmieder S, Begemann M, Kurth I, Schemionek M, Brümmendorf TH, Beier F. Kirschner M, et al. Among authors: rosewich m. Leukemia. 2018 Aug;32(8):1762-1767. doi: 10.1038/s41375-018-0125-x. Epub 2018 Apr 2. Leukemia. 2018. PMID: 29749397 Free article.

2

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies.

Rosewich M, Girod K, Zielen S, Schubert R, Schulze J. Rosewich M, et al. Allergy Asthma Immunol Res. 2016 May;8(3):257-63. doi: 10.4168/aair.2016.8.3.257. Allergy Asthma Immunol Res. 2016. PMID: 26922936 Free PMC article.

3

Long-term lung function in postinfectious bronchiolitis obliterans.

Rosewich M, Eckrich J, Zielen S. Rosewich M, et al. Thorax. 2015 Aug;70(8):792. doi: 10.1136/thoraxjnl-2015-206998. Epub 2015 Apr 28. Thorax. 2015. PMID: 25920327 No abstract available.

4

Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis Obliterans.

Jerkic SP, Michel F, Donath H, Herrmann E, Schubert R, Rosewich M, Zielen S. Jerkic SP, et al. Among authors: rosewich m. Mediators Inflamm. 2020 May 1;2020:4641585. doi: 10.1155/2020/4641585. eCollection 2020. Mediators Inflamm. 2020. PMID: 32410855 Free PMC article.

5

Ultra-short course immunotherapy in children and adolescents during a 3-yrs post-marketing surveillance study.

Rosewich M, Schulze J, Fischer von Weikersthal-Drachenberg KJ, Zielen S. Rosewich M, et al. Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 2):e185-9. doi: 10.1111/j.1399-3038.2009.00953.x. Epub 2009 Dec 8. Pediatr Allergy Immunol. 2010. PMID: 20003062

6

Bronchial allergen challenge using the Medicaid dosimeter.

Schulze J, Rosewich M, Dressler M, Riemer C, Rose MA, Zielen S. Schulze J, et al. Among authors: rosewich m. Int Arch Allergy Immunol. 2012;157(1):89-97. doi: 10.1159/000324473. Epub 2011 Sep 7. Int Arch Allergy Immunol. 2012. PMID: 21912178

7

Bronchial allergen challenges in children - safety and predictors.

Schulze J, Reinmüller W, Herrmann E, Rosewich M, Rose MA, Zielen S. Schulze J, et al. Among authors: rosewich m. Pediatr Allergy Immunol. 2013 Feb;24(1):19-27. doi: 10.1111/pai.12031. Pediatr Allergy Immunol. 2013. PMID: 23331526

8

Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.

Rosewich M, Arendt S, El Moussaoui S, Schulze J, Schubert R, Zielen S. Rosewich M, et al. Pediatr Allergy Immunol. 2013 Aug;24(5):434-40. doi: 10.1111/pai.12068. Epub 2013 Apr 11. Pediatr Allergy Immunol. 2013. PMID: 23578317

9

Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy.

Zielen S, Gabrielpillai J, Herrmann E, Schulze J, Schubert R, Rosewich M. Zielen S, et al. Among authors: rosewich m. Immunotherapy. 2018 Jun;10(7):529-536. doi: 10.2217/imt-2018-0004. Epub 2018 Mar 22. Immunotherapy. 2018. PMID: 29562801

10

Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.

Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J, Rose MA, Rosewich M, Renz H, Zielen S. Schubert R, et al. Among authors: rosewich m. Int Arch Allergy Immunol. 2009;148(3):251-60. doi: 10.1159/000161585. Epub 2008 Oct 10. Int Arch Allergy Immunol. 2009. PMID: 18849616 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters